NR 566 ADVANCED PHARMACOLOGY
FOR CARE OF THE FAMILY
CHAMBERLAIN COLLEGE OF
NURSING | ACADEMIC YEAR 2026/2027
COMPREHENSIVE 300-QUESTION
MIDTERM PRACTICE EXAMINATION
ORIGINAL PRACTICE QUESTIONS
WITH CORRECT ANSWERS AND
RATIONALES
Questions 1–50: Pharmacokinetics, Pharmacodynamics &
Prescribing Principles
1. Which pharmacokinetic process describes movement of a drug from the gastrointestinal
tract into systemic circulation?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B. Absorption
Rationale: Absorption is the movement of a drug from its administration site into systemic
circulation.
2. Which route of administration provides 100% bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
D. Intravenous
Answer: D. Intravenous
Rationale: IV administration delivers the drug directly into systemic circulation, providing
complete bioavailability.
,3. A medication with extensive first-pass metabolism will generally have what characteristic?
A. Increased oral bioavailability
B. Decreased oral bioavailability
C. Increased renal clearance
D. Prolonged absorption
Answer: B. Decreased oral bioavailability
Rationale: Hepatic first-pass metabolism can substantially reduce the amount of orally
administered drug reaching systemic circulation.
4. Which organ is primarily responsible for drug metabolism?
A. Heart
B. Liver
C. Spleen
D. Pancreas
Answer: B. Liver
Rationale: Hepatic enzymes, particularly CYP450 enzymes, metabolize many medications.
5. Which organ is primarily responsible for renal drug elimination?
A. Liver
B. Kidney
C. Lung
D. Pancreas
Answer: B. Kidney
Rationale: The kidneys eliminate many drugs and metabolites through glomerular filtration,
secretion, and reabsorption.
6. A drug's half-life refers to the time required for:
A. Complete elimination
B. Absorption to begin
C. Plasma concentration to decrease by 50%
D. Peak concentration to occur
Answer: C. Plasma concentration to decrease by 50%
Rationale: Half-life is the time needed for the drug concentration in plasma to fall by half.
7. Approximately how long does it generally take a drug to reach steady state when
administered repeatedly?
A. One half-life
B. Two half-lives
C. Four to five half-lives
D. Ten half-lives
Answer: C. Four to five half-lives
Rationale: Most drugs reach approximately 94–97% of steady state after four to five half-
lives.
,8. A loading dose is primarily used to:
A. Reduce adverse effects
B. Reach therapeutic concentrations rapidly
C. Increase renal elimination
D. Prevent drug interactions
Answer: B. Reach therapeutic concentrations rapidly
Rationale: A loading dose quickly achieves the desired plasma concentration.
9. Which pharmacodynamic concept describes the maximum effect a drug can produce?
A. Potency
B. Efficacy
C. Bioavailability
D. Clearance
Answer: B. Efficacy
Rationale: Efficacy refers to the maximum therapeutic effect achievable by a drug.
10. A highly potent drug requires:
A. A larger dose to produce an effect
B. A smaller dose to produce a given effect
C. No receptor interaction
D. Complete renal elimination
Answer: B. A smaller dose to produce a given effect
Rationale: Potency refers to the amount of drug needed to produce a particular effect.
11. An agonist binds to a receptor and:
A. Blocks its activity
B. Activates it
C. Destroys it
D. Prevents absorption
Answer: B. Activates it
Rationale: Agonists bind receptors and produce a biological response.
12. An antagonist primarily:
A. Activates receptors
B. Blocks receptor activity
C. Increases absorption
D. Increases metabolism
Answer: B. Blocks receptor activity
Rationale: Antagonists prevent or reduce receptor activation.
13. Which patient factor commonly increases the risk of drug accumulation?
A. Increased renal function
B. Reduced renal function
C. Increased hydration
D. Young age
, Answer: B. Reduced renal function
Rationale: Impaired renal function can decrease drug clearance and increase accumulation.
14. Which laboratory value is particularly useful when evaluating renal function for
medication dosing?
A. ALT
B. AST
C. Serum creatinine
D. Bilirubin
Answer: C. Serum creatinine
Rationale: Serum creatinine contributes to estimation of renal function and medication
dosing considerations.
15. A medication highly bound to albumin may be affected by:
A. Hypoalbuminemia
B. Hypernatremia
C. Hyperglycemia only
D. Increased platelet count
Answer: A. Hypoalbuminemia
Rationale: Low albumin can increase the unbound fraction of highly protein-bound
medications.
16. Which patient is generally at greatest risk for altered pharmacokinetics?
A. Healthy young adult
B. Older adult with hepatic and renal impairment
C. Healthy adolescent
D. Healthy middle-aged adult
Answer: B. Older adult with hepatic and renal impairment
Rationale: Aging combined with organ dysfunction can substantially alter drug absorption,
distribution, metabolism, and elimination.
17. The CYP450 enzyme system is primarily involved in:
A. Drug metabolism
B. Drug absorption
C. Drug excretion through sweat
D. Receptor synthesis
Answer: A. Drug metabolism
Rationale: CYP450 enzymes metabolize numerous medications, particularly in the liver.
18. A CYP450 inhibitor generally causes levels of a substrate medication to:
A. Decrease
B. Increase
C. Remain unchanged
D. Become inactive immediately
FOR CARE OF THE FAMILY
CHAMBERLAIN COLLEGE OF
NURSING | ACADEMIC YEAR 2026/2027
COMPREHENSIVE 300-QUESTION
MIDTERM PRACTICE EXAMINATION
ORIGINAL PRACTICE QUESTIONS
WITH CORRECT ANSWERS AND
RATIONALES
Questions 1–50: Pharmacokinetics, Pharmacodynamics &
Prescribing Principles
1. Which pharmacokinetic process describes movement of a drug from the gastrointestinal
tract into systemic circulation?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B. Absorption
Rationale: Absorption is the movement of a drug from its administration site into systemic
circulation.
2. Which route of administration provides 100% bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
D. Intravenous
Answer: D. Intravenous
Rationale: IV administration delivers the drug directly into systemic circulation, providing
complete bioavailability.
,3. A medication with extensive first-pass metabolism will generally have what characteristic?
A. Increased oral bioavailability
B. Decreased oral bioavailability
C. Increased renal clearance
D. Prolonged absorption
Answer: B. Decreased oral bioavailability
Rationale: Hepatic first-pass metabolism can substantially reduce the amount of orally
administered drug reaching systemic circulation.
4. Which organ is primarily responsible for drug metabolism?
A. Heart
B. Liver
C. Spleen
D. Pancreas
Answer: B. Liver
Rationale: Hepatic enzymes, particularly CYP450 enzymes, metabolize many medications.
5. Which organ is primarily responsible for renal drug elimination?
A. Liver
B. Kidney
C. Lung
D. Pancreas
Answer: B. Kidney
Rationale: The kidneys eliminate many drugs and metabolites through glomerular filtration,
secretion, and reabsorption.
6. A drug's half-life refers to the time required for:
A. Complete elimination
B. Absorption to begin
C. Plasma concentration to decrease by 50%
D. Peak concentration to occur
Answer: C. Plasma concentration to decrease by 50%
Rationale: Half-life is the time needed for the drug concentration in plasma to fall by half.
7. Approximately how long does it generally take a drug to reach steady state when
administered repeatedly?
A. One half-life
B. Two half-lives
C. Four to five half-lives
D. Ten half-lives
Answer: C. Four to five half-lives
Rationale: Most drugs reach approximately 94–97% of steady state after four to five half-
lives.
,8. A loading dose is primarily used to:
A. Reduce adverse effects
B. Reach therapeutic concentrations rapidly
C. Increase renal elimination
D. Prevent drug interactions
Answer: B. Reach therapeutic concentrations rapidly
Rationale: A loading dose quickly achieves the desired plasma concentration.
9. Which pharmacodynamic concept describes the maximum effect a drug can produce?
A. Potency
B. Efficacy
C. Bioavailability
D. Clearance
Answer: B. Efficacy
Rationale: Efficacy refers to the maximum therapeutic effect achievable by a drug.
10. A highly potent drug requires:
A. A larger dose to produce an effect
B. A smaller dose to produce a given effect
C. No receptor interaction
D. Complete renal elimination
Answer: B. A smaller dose to produce a given effect
Rationale: Potency refers to the amount of drug needed to produce a particular effect.
11. An agonist binds to a receptor and:
A. Blocks its activity
B. Activates it
C. Destroys it
D. Prevents absorption
Answer: B. Activates it
Rationale: Agonists bind receptors and produce a biological response.
12. An antagonist primarily:
A. Activates receptors
B. Blocks receptor activity
C. Increases absorption
D. Increases metabolism
Answer: B. Blocks receptor activity
Rationale: Antagonists prevent or reduce receptor activation.
13. Which patient factor commonly increases the risk of drug accumulation?
A. Increased renal function
B. Reduced renal function
C. Increased hydration
D. Young age
, Answer: B. Reduced renal function
Rationale: Impaired renal function can decrease drug clearance and increase accumulation.
14. Which laboratory value is particularly useful when evaluating renal function for
medication dosing?
A. ALT
B. AST
C. Serum creatinine
D. Bilirubin
Answer: C. Serum creatinine
Rationale: Serum creatinine contributes to estimation of renal function and medication
dosing considerations.
15. A medication highly bound to albumin may be affected by:
A. Hypoalbuminemia
B. Hypernatremia
C. Hyperglycemia only
D. Increased platelet count
Answer: A. Hypoalbuminemia
Rationale: Low albumin can increase the unbound fraction of highly protein-bound
medications.
16. Which patient is generally at greatest risk for altered pharmacokinetics?
A. Healthy young adult
B. Older adult with hepatic and renal impairment
C. Healthy adolescent
D. Healthy middle-aged adult
Answer: B. Older adult with hepatic and renal impairment
Rationale: Aging combined with organ dysfunction can substantially alter drug absorption,
distribution, metabolism, and elimination.
17. The CYP450 enzyme system is primarily involved in:
A. Drug metabolism
B. Drug absorption
C. Drug excretion through sweat
D. Receptor synthesis
Answer: A. Drug metabolism
Rationale: CYP450 enzymes metabolize numerous medications, particularly in the liver.
18. A CYP450 inhibitor generally causes levels of a substrate medication to:
A. Decrease
B. Increase
C. Remain unchanged
D. Become inactive immediately
